CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT
-
Alcaraz sets up Queen's final clash with Lehecka
-
MLB suspends Padres pitcher three games for hitting Ohtani
-
Belarus opposition leader freed from jail after US mediation
-
Medvedev dispatches home hope Zverev to reach Halle final
-
Tens of thousands join pro-Palestinian marches in London and Berlin
-
India star Bumrah strikes before Duckett and Pope hold firm in 1st Test
-
Nottingham Forest boss Nuno signs new three-year contract
-
Ill Mbappe out of second Real Madrid Club World Cup clash
-
Lehecka stuns Draper to reach Queen's final
-
Marc Marquez continues MotoGP dominance by winning Mugello sprint
-
Bangladesh draw first Test with Sri Lanka after rain hampers play
-
Pant scores India's third hundred in 1st Test before England hit back
-
Vondrousova surprises Sabalenka to reach Berlin final
-
Mexican boxing legend Alvarez promises Crawford bout will be one of his 'best'
-
French scientists find new blood type in Guadeloupe woman
-
Farrell adamant Lions 'won't suger-coat' Argentina loss
-
Malaysia's Dayaks mark rice harvest end with colourful parade
-
Shanto clinches second ton as Bangladesh set Sri Lanka 296-run target
-
Israel says killed three Iranian commanders in fresh wave of strikes
-
Crusaders out-muscle Chiefs to clinch 15th Super Rugby crown
-
VP Vance says US troops still 'necessary' in Los Angeles
-
Australian opener Konstas says he has 'come a long way'
-
'Survive, nothing more': Cuba's elderly live hand to mouth
-
Last member of K-pop megaband BTS to finish military service
-
Olympic balloon to rise again in Paris
-
Samaranch Senior -- controversial diplomat who saved the Olympics
-
As sports embrace gender tests, Coventry and IOC may follow
-
Flamengo floor Chelsea at Club World Cup, Bayern edge out Boca
-
Bayern overcome battling Boca to reach Club World Cup last 16
-
Jeeno extends lead at Women's PGA Championship
-
Israel says delayed Iran's presumed nuclear programme by two years
-
Japan-US-Philippines coast guards simulate crisis amid China threat
-
Flamengo floor Chelsea at Club World Cup, Bayern face Boca
-
Tech-fueled misinformation distorts Iran-Israel fighting
-
Panama declares state of emergency over deadly pension protests
-
Does Hospital Indemnity Insurance Help Cover Recurring Stays?
-
Trump says Iran has 'maximum' two weeks, dismisses Europe peace efforts
-
Defending champions Toulouse hold off Bayonne to reach Top 14 final
-
Teams from 'south' have Club World Cup heat advantage: Dortmund's Kovac
-
'It's only match one' says Itoje after Lions mauled by Pumas
-
Fleetwood, Thomas and Scheffler share PGA Travelers lead
-
Mexican authorities rescue 3,400 trafficked baby turtles
-
Maresca accepts Chelsea were second best in Flamengo loss
-
Global stocks mixed, oil lower as market digests latest on Iran
-
Argentina's Kirchner urges backers not to gather as police deploy
-
Lions slump to warm-up defeat by Argentina
-
Habz, Stark light up Diamond League as Girma banishes Paris blues
-
Haliburton warns Pacers of 'poison' of outside noise before NBA Finals game 7
-
Benfica knock out Auckland in delayed Club World Cup romp
-
Benfica knock out Auckland in Club World Cup romp
CS Diagnostics Corp. CSDX to Present at the Small Cap Growth Virtual Investor Conference on June 26, 2025 at 12:30pm EDT
NEUSS, DE / ACCESS Newswire / June 18, 2025 / CS Diagnostics Corp. (OTCQB:CSDX) a global leader in innovative healthcare solutions announced its participation in the Small Cap Growth Virtual Investor Conference hosted by Virtual Investor Conferences (VIC) on Thursday, June 26, 2025. The live, interactive presentation will provide investors with real-time access to company executives with the opportunity to ask questions directly during the webcast. For those unable to attend the live session, a recorded version will be available on demand following the event.
Event Details
Date: June 26, 2025
Time: 12:30 - 1:00 pm EDT
Presenters: Mr. Thomas Fahrhöefer, Chairman, President of the Board
Mr. Mohammad EsSayed, GCFO, Vice President of the Board
Investors are encouraged to pre-register and add the event to their calendars. Registration Link: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/4998796/cs-diagnostics-corp-otcqb-csdx
Presentation Highlights: The company will feature its flagship products MEDUSA and CS- Protect Hydrogel while highlighting the CS Group's global expansion including its subsidiaries: CS Interpharm (UAE), CSPharma (Germany), CS Diagnostics Corp. (USA), and CSI Turkey (Turkey).
Thomas Fahrhöefer, Chairman, President of the Board at CS Diagnostics Corp. mentioned:
"This is a great opportunity to present ourselves to a wide network of investors and to define our long-term vision in the healthcare space. Our focus remains on scalable, sustainable medical innovations that address global healthcare challenges."
Mohammad EsSayed, GCFO, Vice President of the Board at CS Diagnostics Corp. commented:
"Our group's financial architecture is built to support strategic growth with an emphasis on transparent operations, long-term shareholder value, and cross-market regulatory alignment."
Why Attend?
Virtual Investor Conferences (VIC) offer a dynamic platform for direct engagement with CS Diagnostics Corp.'s leadership. Investors will gain exclusive insights into CSDX R&D pipeline and commercialization strategies, access to senior management during live Q&A etc.
Forward-Looking Statements
This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the timing and granting of regulatory and other third party consents and approvals, uncertainties regarding the Company's or any third party's ability to execute and implement future plans, and the occurrence of unexpected events.
Actual results achieved may vary from the information provided herein because of numerous known and unknown risks and uncertainties and other factors.
For further information please email: [email protected]
SOURCE: CS Diagnostics Corp.
View the original press release on ACCESS Newswire
D.Sawyer--AMWN
